Literature DB >> 20057324

Clofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemia.

Birol Baytan1, Ozlem Ozdemir, Adalet Meral Gunes, Osman Dönmez.   

Abstract

Clofarabine has significant efficiency in children with relapsed or refractory leukemia. In previous pediatric trials, various adverse effects have been described. In this case, we report a child with refractory acute lymphoblastic leukemia who developed fatal capillary leak syndrome during clofarabine therapy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20057324     DOI： 10.1097/MPH.0b013e3181bf298b

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


  3 in total

Review 1.  Anticancer Drug-Induced Capillary Leak Syndrome.

Authors:  Hassan Izzedine; Alexis Mathian; Zahir Amoura; Jia H Ng; Kenar D Jhaveri
Journal:  Kidney Int Rep       Date:  2022-02-25

2.  Clofarabine desensitization: A case report: Leukemia research reports.

Authors:  Sarah M Hayes; Justin A Wasko; Erica Dahl Warlick
Journal:  Leuk Res Rep       Date:  2017-02-13

3.  Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report.

Authors:  Ahmed H Al Sharie; Yazan O Al Zu'bi; Sarah Al Sharie; Hawra A Baydoun; Farah H Atawneh; Osama Alshari; Dima Albals
Journal:  Memo       Date:  2022-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.